ISMP is taking a formal stand on the need to eliminate any remaining barriers to a standardized appearance of bioequivalent brand and generic medications. In a recent ABC News special on generic ...

The Food and Drug Administration (FDA) announced a proposal to withdraw the approval of two generic versions of Concerta (methylphenidate HCl; Janssen) extended-release capsules indicated for ...

TG Therapeutics announces that Briumvi's late-stage ENHANCE study met its goal, supporting a potential single-infusion ...

Changes in the color of generic antiepileptic drugs increase the likelihood patients will fail to refill a prescription, according to a study in JAMA Internal Medicine, formerly Archives of Internal ...

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only ...

In order to discuss the appropriateness of substituting one drug for another, it is important to understand certain key terms. [10] Pharmaceutical equivalents are drug products containing the same ...

BEECH ISLAND, S.C.--(BUSINESS WIRE)--Ambio, Inc., an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, announced today that a ...

SAINT LAURENT, Quebec, May 29, 2012--IntelGenx Corp. ("IntelGenx") today announced the completion of the pivotal bioequivalence study for a novel oral thin-film formulation of Rizatriptan, the active ...

Natco Pharma and Lupin gained FDA approval for bioequivalent generic eribulin mesylate injection, potentially reducing ...

Natco Pharma and Lupin receive U.S. FDA approval for generic Eribulin Mesylate, a treatment for metastatic breast cancer.

It’s a good time to be an advocate for lower drug prices. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Congress is happily hauling drug company ...